Wang et al. report that Gn-specific mAbs from SFTS survivors exhibit broad and potent neutralization, with two providing complete protection in a lethal mouse model. This work maps the Gn antigenic landscape and establishes a deep mutational scanning platform coupled with structural validation for bunyavirus antibody discovery.